HyTest Ltd., a continually expanding Finnish biotechnology company known for high quality products for assay development and research applications, signed an exclusive agreement with Affinity Life Sciences to develop and manufacture research assays for their proprietary SES-BNP technology for detection of proBNP / BNP. ...
Milford, NH. Prediction Sciences and Affinity Life Sciences , today announced a development and commercialization agreement of a biomarker assay, cellular fibronectin; for the identification and use of a research diagnostic marker for stroke, vascular damage and hemorrhagic transformation (HT). Upon completion of development and...
Affinity Life Sciences, Inc. and SRC Acumen, LLC are announcing the continued production of freeze-dried qPCR and toxin assays. As part of this agreement, Affinity Life Sciences will manufacture these products exclusively for SRC Acumen. SRC Acumen’s assays are unique in their ability to provide near...